Future-Proofing Behavioral Healthcare: Nicki Tessler, DVP, UHS

•

1 like•455 views

Future-proofing behavioral healthcare- presentation for mHealth Israel by Nicki Tessler, Division Vice President, Behavioral Health, Universal Hospital Services. Key points: - Behavioral healthcare delivery must improve to meet the needs of this new world. - For patients to reap the benefit of these investments, there needs to be Technological advancement, greater access to treatment, ore engaging and integrated care. - Integrated platforms will enable more coordinated treatments as they combine clinical care, Social support, Employment and housing assistance, Patient empowerment strategies - Srategic Focus: Ecosystem Desirability, Business Model Viability, Technical Feasibility, Innovation Hub - Innovation HUB: Remote collaboration, Emotion sensing problem sets, Machine learning and sensor fusion for pain management, AR real-time psychiatric assistance - Project behavioral health expertise into every domain that behavioral health is absolutely necessary - Create Unique Advantage: Find the blend and the way those can work together to create a winning combination - Establish a Culture of Growth - Create a portfolio of innovation that moves the needle for the behavioral health industry - Invest in outcomes not ideas through rapid experiments that prove product market fit - Build a system of governance and delivery to maximize innovation portfolio ROI The data and knowledge we’ve gained during this pandemic will prove foundationally vital

Health & Medicine

Future-Proofing
Behavioral
Healthcare
3/24/2021

2
© 2021 Innovation Hub
Behavioral Health Needs Innovation
Behavioral healthcare delivery must
improve to meet the needs of this new
world.
Patients need care that is:
Rapid Incentivized
Widespread

3
© 2021 Innovation Hub
Improving
Clinical
Outcomes
3
Technological
advancement
More engaging
and integrated
care solutions
Greater access
to treatment
For patients to reap the benefit of
these investments, there needs to
be...

4
© 2021 Innovation Hub
Activating Digital Solutions
Integrated platforms will enable more coordinated
treatments as they combine:
Clinical care Social support Employment and
housing assistance
Patient
empowerment
strategies

6
© 2021 Innovation Hub
Ecosystem Desirability
Business Model Viability
Technical Feasibility
Innovation Hub

7
© 2021 Innovation Hub
Innovation Hub
Inside the building
Examples:
• Amplify acceleration
• Existing initiatives
Innovation Hub 2.0
New opportunities beyond our walls
Examples:
• Remote collaboration
• Emotion sensing problem sets
• ML + sensor fusion for pain management
• AR real-time psychiatric assistance
• IoT+ voice + affective computing for addiction recovery

8
© 2021 Innovation Hub
Project behavioral health
expertise into every domain
that behavioral health is
absolutely necessary

9
© 2021 Innovation Hub
Find the blend and the way those can work together to create
a winning combination

Create Unique Advantage
Enable assets that we have at our
disposal – relationships at the breadth of business,
different skills/expertise, our operational know-how, will
help innovation really scale and grow dramatically

Bring together two worlds – the world of the corporate
with all its scale, expertise and know-how in its markets
with the agility and pace which is what we see in VC
and PE markets

10
© 2021 Innovation Hub

Establish a Culture of Growth
The skill set is a different skill set, not a better skill set.
Create an environment where the
actual source of rewards are
mirrored similar to a VC/PE firm

Real alignment of personal
and organizational reward
with achievement of
milestones and growth

Build human talent so we have
a high growth, high performing
environment with a reward
system reflecting the best
practices you see
so we actually have equity

11
© 2021 Innovation Hub

3 Dimensions
Create a portfolio of
innovation that moves the
needle for the behavioral
health industry

Build a system of
governance and delivery to
maximize innovation
portfolio ROI

Invest in outcomes not
ideas through rapid
experiments that prove
product market fit

12
© 2021 Innovation Hub
Summary
Accelerate existing Innovation Hub
Expand into new domains
Build talent pool
Co-create offerings with real ROI
Shine as an innovation powerhouse

13
© 2021 Innovation Hub
Behavioral Healthcare is Evolving Fast
By innovating the solutions to
today’s problems, we can
ensure better lives for
tomorrow’s patients.
As the needs within the behavioral health sector
continues to grow, the data and knowledge we’ve
gained during this pandemic will prove
foundationally vital.

More from Levi Shapiro

Presentation by Mark Coticchia, Chief Innovation Officer, Baptist Health, for mHealth Israel community, September, 2023. Baptist Health has internationally renowned centers of excellence in cancer, cardiovascular care, orthopedics and sports medicine, and neurosciences. A not-for-profit organization supported by philanthropy and committed to its faith-based charitable mission of medical excellence, Recognized by Fortune as one of the 100 Best Companies to Work For in America and by Ethisphere as one of the World’s Most Ethical Companies.Innovation is paramount to health system’s performance and reputation. Becker’s 2019 Advisory Board survey revealed innovation and technology ranked as the top priority among healthcare finance professionals - up from eighth in 2018. 90% healthcare/life science leaders agree that the pandemic will fundamentally change the way they do business, requiring new products, services, processes, and business models (McKinsey: Innovation Through Crisis Survey). Innovation has been proven to help health systems in many ways. A capability and culture of innovation accomplish numerous goals: Innovation capability and culture improve the care and work environment. They enhance the reputation through recognition for discoveries made at and through Baptist Health. They aid in the recruitment and retention of top talent. And they help systems harness money that otherwise would be leaving the system – licensing revenues and investment returns and corporate research support and donor revenues. Successful Programs - Common Underpinnings. Innovation as a strategic, institutional priority Program built on institutional assets and centers of excellence Experienced, professional team Technology development and sourcing, Dedicated, long term support. Doing healthcare innovation well at a large enterprise takes a highly specialized team and skill set. Collectively, they need to have deep knowledge of healthcare regulation, medical procedures, patient safety, business development, transactions, business law, innovation markets, entrepreneurship, venture capital, commercialization, tech transfer, organizational change management, and much more. Programs- services, technology management, corporate co-creation, global medical service lines and facilities; Focus on market opportunity vs. technology; Select & concentrate on winners; Operate as a business; Proactive in new company formation; Progress, milestones, preliminary results; Building New Innovation Pathways; Improving Treatment for Cancer Patients; Predicting & Preventing Heart Attacks; Improving Outcomes in Cardiac Care; Enhancing a Culture of Innovation at Baptist Health & South Florida; Cleerly, TriVentures, COTA; Innovation is paramount to health system’s performance and reputation. Baptist Health has established an innovation function predicated on best practices and tailored to its assets and the opportunities extending from Miami’s economic growth

Baptist Health- Engineering the Future of Healthcare

Levi Shapiro

Presentation by Yael Klionsky, YEDA, for the mHealth Israel community in September, 2023. Title: Challenges in Academic Technology Transfer. Examples- Transplantation Immunology and Immunometabolism. Efranat Pharma was developing an anticancer immunotherapy treatment based on a natural plasma protein molecule. From target discovery to clinical validation. Clinical-stage drug discovery and development company utilizing a broadly applicable, predictive computational discovery platforms to identify novel drug targets and new biological pathways and develop therapeutics in the field of cancer immunotherapy. To allow SOCIETY to benefit from discoveries made at the academic institution. To enable SCIENTISTS to transfer their new technologies to the market. To create an additional source of INCOME for the INSTITUTE so that more independent research can be conducted. Three important elements that make an idea patentable: 1) The invention must be new: the same idea can’t have been published before in any form; 2) There must be some inventive step of ‘non-obviousness’. This can be hard to define and depends on the context; 3) The disclosure in a patent must be sufficient for a skilled person to reproduce the invention with only routine effort; Technology Transfer Company - modus operandi; OUR PURPOSE- To provoke transformative scientific breakthroughs that will shape the future of humanity; SCIENTIFIC STAFF- 300 Principal investigators, >2,000 Research students and PhDs; 5 FACULTIES – BASIC SCIENCE, Biology, Physics, Biochemistry, Math/CS Chemistry; Generated IP- 57% in Life Science & Biotech; Among the Highest Income per Researcher Worldwide; 1959 (First TTO outside the US); Today- More applications per PI than in most Ivy league universities; Copaxone- >$30B ANNUAL SALES BASED ON Weizmann IP; 20 new licenses per year and 10 new companies per annum; www.yedarnd.com

YEDA Techn Transfer at Weizmann Institute- Discord and Challenges in Academic...

Levi Shapiro

Overview of activities in Life Science of Hadasit, the technology transfer arm of Hadassah Hospital in Jerusalem. Includes details about Jerusalem Biodesign program; spinouts like Brainwatch; details about tech transfer (the Secret Engine Behind Israel’s Success); relationship and examples of TTOs enabling Israel's greatest success stories; contrasting of Adademia (Scientific driven research, Creation of new knowledge, Publication, Sharing of Material, Social responsibilities) and Industry (Applied research & specific objectives, Develop new products, Product development, Secrecy and patent protection, Organization responsibilities); Development gap between initial inventions and product development; the Art of translation (from academic research to medical companies); Tech transfer transforms cutting-edge research into marketable healthcare technologies; LICENSING TO EXISTING COMPANIES; SPINNING OFF STARTUPS; CO-DEVELOPMENT OF JOINT IP; Technology Transfer Offices from Academia/Research Hospitals – to Industry; Overview of Hadassah and Hadasit (TECHNOLOGY TRANSFER COMPANY AND INNOVATION ENGINE OF HADASSAH UNIVERSITY HOSPITALS); Examples of “HADASSAH MADE” PRODUCTS IN THE GLOBAL MARKET; RECENT TECH TRANSFER SUCCESS; Example- Lineage Exclusive Worldwide Collaboration with Genentech Opregen® RPE Cell Therapy for the Treatment of Ocular Disorders; HADASIT PILLARS- NURTURING INTERNAL INNOVATION, Tech Transfer, EXTERNAL INNOVATION. External- SERVICES & COLLABORATIONS WITH COMPANIES, BIOHOUSE FOR STARTUPS, DIGITAL HEALTH ACCELERATOR); Internal Innovation- NURTURING INTERNAL INNOVATION, HADASSAH SEED FUND, JERUSALEM BIODESIGN PROGRAM; TYPES OF RELATIONS WITH EXTERNAL COMPANIES- CONSULTING, SAB, CLINICAL TRIALS, R&D SERVICES, DATA LICENCE, ALPHA/BETA SITE, PILOTS, DESIGN PARTNERSHIPS.

HADASIT: Tech Transfer and More in Life Science

Levi Shapiro

Presenting to Investors and the Media, lecture by Drew Levinson, LifeSci Communications to mHealth Israel. Three sections: Making a good presentation, Handling interviews with reporters and Answers that resonate. PRESENTING TO INVESTORS AND THE MEDIA- Compelling delivery, Commanding a room, • Lasting Impact. A good presentation includes Information, Motivation and Excitement. Never put them to sleep. Audience impact includes content, credibility and delivery. Decisions are made leading to potential partnerships, winning business, so much more than a deck, your business, your brand, you. How to captivate begins with storytelling and conversation. More than features- benefits, humanize, positive impact. Don't complicate your message with jargon. Feel the passion- contagious, vision, determination. Know your audience- who are they, what do they know about you, how much do they know, interests, concerns. Articulate your vision- see it, feel it, believe in it. Take them on your journey- compelling narrative, make it personal, why are you doing this, inspiration. Your team- experienced, knowledgeable, aligned, execute. Risks and challenges- recognize, address, plan to mitigate. Test drive your room. What does it look like? Where is the podium? Where will I be standing? Where will you be sitting? Feel comfortable. Three parts to attention. The beginning- attention, interest, what's in it for them, entusiasm, preview. The middle- core, insights, challenges, solutions, relatable. The ending- summary, reinforce, messages, benefits, call to action, keep the momentum going. How to answer questions. The Four R's: repeat, reinforce, refer, remember. Talking to reporters- necessity; Good interview can enhance reputation; Bad interview can tarnish reputation; Preparation is vital. Shapes public opinion: Elevates your brand; Establishes authority; Showcases your business; A bridge; Reputation; Trust; Visibility. Know the reporter. Audience; What have they written; Previous stories; Questions asked. Concise- clear, succinct, engaging. Make it relatable: Stories; Anecdotes; Experiences; Examples; Metaphors; Connect. Honesty and transparency. It is okay not to know every answer. You don’t have to answer every question. Control the narrative. What not to do when talking to reporters. Come up with another way to say no comment. What to wear- solid colors, blues and grays, nothing distracting. Expertise, passion, vision, lasting impression, connections. High stakes, high rewards. Preparation; Know your audience; Deliver with confidence; Enthusiasm; Authenticity. Begin the journey. Engage in dialogue; Build relationships; Inspire trust and confidence; Valued; Enlightened; Motivated and excited.

Presenting to Investors & the Media.pdf

Levi Shapiro

Nissan Elimelech, Founder, Augmedics: How I Built the World's First XR Surgic...

Levi Shapiro

Overview by Beyeonics CEO, Ron Schneider, about the company. Beyeonics One is the first ophthalmic exoscope with an augmented reality surgical headset. It is a high-definition, fully digital imaging platform enabling surgeons to see a magnified, three-dimensional (3D) image of the surgical field. The small footprint, the fast setup, automation, and zero turnover time between procedures all contribute to the efficiency operating rooms strive for. Over 3000 cases to date. Unconstrained Movement. Unconstrained workflow. Data connectivity. Designed for continuous innovation.

Beyeonics CEO, Ron Schneider, Advances in Medical XR

Levi Shapiro

XRHealth is revolutionizing healthcare, bringing patient care into the Metaverse. Includes a description of the TeleHealth Platform. Lessons Learned – Building the clinical Metaverse. Last mile delivery Building a product in the Metaverse is easy – getting people to use it is hard. Virtual Care can’t be based only on XR. HMDs bring friction – Charging, Guardian, Safety, Passwords etc. Expanding virtually in a brick & mortar payer environment. Once you cross the chasm – adherence/ satisfaction/retention goes ballistic. Patient Outcomes- Patients report significant improvement in symptoms following treatment. Adherence - patients follow Home Exercise Plans as prescribed. 92.2% with XRHealth vs 50% with regular treatment. Patient satisfaction - 85 NPS vs 38 NPS in healthcare 93.3% patient retention -complete treatment cycle as prescribed. XRHealth Luna AI Reduces Hot Flashes and Improves Psychological Well-Being in Women with Breast and Ovarian Cancer: A Pilot Study. Virtual reality immersion compared to monitored anesthesia care for hand surgery: A randomized controlled trial. Lessons Learned – Autism Spectrum Disorder. The future of the Mediverse.

XRHealth Founder, Miki Levy

Levi Shapiro

April, 2023 presentation by Gil Bashe, Global Chair, Health Practice, FINN Partners. Insights and analytics, in collaboration with Galen Growth, tracking Digital Health collaboration, adoption, integration, and best practices across the leading US Health Systems. There is a section about focus areas for digital health in health systems and hospitals. The most active health systems are partnering more in diagnosis and have a higher share of digital tools for research. Comprehensive breakout of digital health activities at the Top 10 players: Mayo, Mount Sinai, Cleveland Clinic, Sloan Kettering, Massachusetts General, Northwell, Cedars Sinai, Brigham & Women's, InterMountain. Global breakout of health systems with digital health partnerships at scale. Geographical breakout of digital health partner headquarters (by region). Strong preference for B2B business model. 1/3 of digital health partnerships with Early Stage venture companies. Emphasis is on strong clinical evidence. Portfolio size allows greater diversity. Cluster distribution depends on therapeutic area. Digital health analytics breakout including alpha score, venture similarity score, venture valuation, team signal, partnership signal, evidence signal.

Digital Health in US Health Systems.pptx

Levi Shapiro

Course Syllabus (Digital Rosh): The Future of Digital Medicine- Biology, Gene...

Levi Shapiro

Overview of Israel's leading BioFoundry, Alagene by Roni Cohen, CEO. Overview of Synthetic Biology- Taking biology into engineering mode. Using synthetic genes, to program cells to become factories to make devices, sensors, pharmaceuticals, renewable chemicals, fuels and food. Alagene has four partners with complementary expertise. Hylabs is an established and experienced, highly regulated service company. Reichman University is an academic partner with a commercialization mindset. The Israel Innovation Authority is the government and Aleph VC is an investment firm. Alagene is a home for innovation and R&D center in SynBio, serving as a one-stop—shop for knowledge, methods, and instrumentation to enable our customers in Israel and worldwide to get to their proof of concept. Alagene is anend to end Infrastructure supporting gene & host optimization in microbial systems. The infrastructure enables two Major Implementations- Biomanufacturing and Direct Microbial Application. One example is the development of a Dairy Milk Producing System, using Genetic Optimization and Process Optimization and Validation. Finally, Alagene shared the following recent project examples: Computational prediction for introducing new genes into microbes; Precision fermentation for yeast producing dairy proteins; Bio production of psychoactive / cannabinoid molecule in yeast; Bio production of growth factors for the cultured meat industry; Developing new inhouse tools to support strain optimization; Bio production of egg protein; Computational modeling of full metabolic network in Algae; Bio production of rare sugars with a low glycemic index.

Alagene BioFoundry: Releasing the Genie Out of the Bottle

Levi Shapiro

Snapshot of the global digital health investment and innovation landscape, Q3 2022, prepared by FINN Partners and Galen Growth. Includes digital health funding history, 2021 digital health investment funding breakouts, winners and losers in 2022 digital health venture funding, global vernture disribution by therapeutic area, venture distribution by stage, regulatory filings by digital health area, change in venture funding by therapeutic area, global digital health funding across regions, top funded therapeutic areas, venture funding in key digital health innovation clusters and geographies, digital health funding across regions, 2022 digital health in Israel, QoQ digital health funding by region, QoQ digital health funding, five year trended digital health funding across regions, noteworthy exits in MENA, M&A, Medigate, Breezometer, AIDOC, Vayyar, Viz.ai, Cathworks, Hello Heart, Israel venture funding and exits

Digital Health Ecosystem- 2022 3rd Quarter Report

Levi Shapiro

Overview of the EU medical technology and digital health regulatory framework by Ulf Grundmann and Elisabeth Kohoutek of King & Spalding LLP. Topics include regulatory scope and definitions, classification and conformity assessment, placing a device on the EU Market, UDI and EUDAMED, Supply Chain Obligations, PMS and Vigilance. MDR covers diagnosis, prevention, monitoring, prediction, prognosis, treatment, or alleviation of a disease. ‘Medical Devices’ means any instrument, apparatus, appliance, software, implant, reagent, material or other article intended by the manufacturer to be used, alone or in combination, for human beings. The Regulation covers all devices for cleaning, sterilizing or disinfecting other medical devices, reprocessed single-use medical devices, and certain devices with no intended medical purpose.

EU Medical Device Regulatory Framework_Dec, 2022

Levi Shapiro

Global State of Digital Health, Q3 2022, prepared by Finn Partners and Galen Growth. While most analyses suggest digital health investment is declining, that’s a superficial assessment. Last year – when patients were separated from the health professional community – investors from all sectors jumped in with investments to learn and save their business models. That investment surge was from exuberance. Now, the monies being deployed are strategic. More important, 2022 numbers are far higher than the pre-pandemic equity invested in 2019. While more than 60% of the total venture funding value comes from North America, on a regional level, the Middle East (primarily Israel by 92% and the United Arab Emirates) set record highs in venture funding in Q2 2022. Europe maintains momentum throughout 2022 and has not experienced the quarter-on-quarter decrease in venture funding seen in North America. Regions with increased investment correspond to established regulatory, public health and payer systems that prioritize digital health use. Israel – and Israeli-based entrepreneurs – need to keep their profiles high.

FINN Partners Global State of Digital Health Q3 2022

Levi Shapiro

Digitally powered participant-directed studies. A Strategy for Decentralized Care. The Evolution of the Digital Patient Experience in Oncology & opportunities for Human Augmented Intelligence and Touch. Outlne: Precedent and example; Opportunities for Artificial Intelligence and/or Machine Learning? The human touch to augment technology; Challenges from a behavioral economics standpoint; Future directions. Digitally powered participant-directed studies are the right direction and may be the new reality. Patient Symptoms During Their Cancer Journey. We must shift our focus to the ‘other’ 99% of time. Patient centricity unrestricted by provider encounters. Patient Generated Health Data. Evolving the Digital Patient Experience in Oncology. AI in Health & Medicine. TREATING THE WHOLE PERSON; Health coaching to address social determinants to: Solve the 4000-hour problem; Keep patients healthy at home; Close care gaps between clinic visits; Motivate healthy behavior changeto drive better outcomes. Digital Health Possibilities for Community-Based Support. Insights from a Pilot of Digital Health Coaching. Pilot Study Data. Outcomes of a Pilot Study Exploring the Role of Digital Health Coaching for Men with Prostate Cancer. Data, Healthcare and Technology...REMEMBER THAT THERE ARE SILOS INSIDE OF EACH OF THESE SILOS – THEY ARE THEMSELVES NOT MONOLITHS. EMPHASIS SHOULD BE THAT WE ARE NOT ONLY CREATING A BRIDGE TO OPEN COMMUNICATION. WE ARE ALSO CREATING A NEW PERSON WHO HAS EXPERTISE IN ALL AREAS BROADLY – NOT ONLY JUST THESE 3.

Digitally powered participant-directed studies- Strategy for Decentralized Ca...

Levi Shapiro

AI and the Future of Healthcare, Siemens Healthineers

Levi Shapiro

A Peek into the Future of Health Systems, by Mark Coticchia, Corporate Vice President, Baptist South Florida, Oct 31, 2022. Context- Skate to where the puck is going. Quote from Sami Inkinen (Founder, Virta Health), "If you want to disrupt an industry like healthcare, you have to do it in a non-disruptive way". Digital Health Care in the context of health system transformation. The direction is towards "Digitally Enhanced Health Care" and personalized medicine. Emphasis on Patient Engagement. Transformation from stand alone facilities to Hospital SuperCenters. Importance of culture, including empathy. Role of staffing. Emphasis on Preventive Medicine.

A Peek into the Future of Health Systems, Mark Coticchia, Baptist Health

Levi Shapiro

The Speed of Change is Faster Than Our Response, presentation by Howard Yana Shapiro, Chief Agiculture Officer, Mars, Inc., for the mHealth Israel community, September 29, 2022. Howard-Yana Shapiro, PhD is Senior Fellow College of Agricultural & Environmental Sciences, University of California, Davis; Distinguished Senior Fellow Resilient Landscapes CIFOR-ICRAF; Venture Partner, TO VC. 'Wicked' is the term used to describe some of the most challenging and complex issues of our time, many of which threaten human health. A convergence of technologies enables us to work with biology in entirely new ways. A chip that rivals the human brain. In 2019, Cerebras Systems unveiled a record 1.2-trillion-transistor chip. This is about 10 times more transistors than neurons in a human brain. Analyzing biological systems at the molecular level. Advances in mass spectrometry allow us to readily see almost every molecule in a biological system. Genetic technologies are now more accessible than ever. Advances in genetic technologies now allow everyone to read and write in the languageof biology. Heroines, Heroes andHumankind. Barbara McClintock, Cytogeneticist. Jumping genes and transposons. First evidence for wandering DNA segments came from McClintock’s experiments with Native American maize. She identified changes in the color of kernels that made sense only by postulating that some genetic elements move from other genome locations into the genes for kernel color. These transposable elements movefrom one site to another in a cell’s DNA; they are present in both prokaryotesand eukaryotes. Nitrogen fixation in a landrace of maize is supported by a mucilage-associated diazotrophic microbiota. Analysis of the mucilage microbiota indicated that it was enriched in taxa for which many known species are diazotrophic, was enriched for homologs of genes encoding nitrogenase subunits, and harbored active nitrogenase activity as assessed by acetylene reduction and 15N2 incorporation assays. Field experiments in Sierra Mixe using 15N natural abundance or 15N-enrichment assessments over 5 years indicated that atmospheric nitrogen fixation contributed 29%–82% of the nitrogen nutrition of Sierra Mixe maize. Gurdev Khush, Agronomist and geneticist. Agriculture scientists and geneticists need to work overtime to meet the ever-growing human need for foodand to alleviate hunger and poverty. 1985: IR-64 a high-quality,high-yielding mega variety. Gene editing and CRISPR. Editing a gene using CRISPR/Cas9. Genetic modification of flavone biosynthesis in rice enhances biofilm formation of soil diazotrophic bacteria and biological nitrogen fixation. Improving Biological Nitrogen Fixation (BNF) in cereal crops is a long-sought objective. Hunger + malnutrition = stunting. Stunting prevalence worldwide. Stunting caused by chronic hunger and malnutrition =physical, neurological,economic loss. Key figures in the 2019 FAO report on Africa. We need to produce plants that are bred

mHealth Israel: The Speed of Change is Faster Than Our Response_Howard Yana S...

Levi Shapiro

Presentation by Avner Finger, Head, R&D, Phibro, Unmet R&D Needs and Opportunities – Farm animals. Phibro business includes Medicated Feed Additives includes Antibiotics, Anticoccidials, Antimicrobials, Bloat Control, Anthelmintics. Vaccines. Fully Licensed includes Autogenous, Poultry, Swine, Bovine, Aqua. Nutritional Specialties include Immune Modulators, DCAD Solutions, Yeast Solutions, Mycotoxin Solutions, Phytogenic Feed Additives, DFM Solutions. MVP Adjuvants. Mineral Nutrition. Ethanol Performance. Plant Science. World meat production. Disease Pressure on the Rise. Intensive livestock production. Antimicrobial resistance. Global warming. Disease vectors prevalence. Global trade and travel. Major Challenges. Animal Protein Supply. Food Safety. Zoonotic diseases. Sustainable production. Vaccines - Our Most Effective Tool. All farmed animals are vaccinated against at least several diseases. Animal vaccines are based on some of the most advanced technologies. However…We Continue to Require Real Innovation. Rapid and accurate diagnostic tools. Vaccine platforms. Mass application.

mHealth Israel_Unmet Needs and Opportunities – Farm animals

Levi Shapiro

September 19, 2022 presentation about Animal Health Landscape- by Andras Bolcskei, Executive Vice President & Global Commercial Lead, CEVA Sante Animal Health. Three part agenda covers Global macroeconomic outlook, Animal Health industry trends, Implication on the Animal Health industry. Inflation Growth and Unemployment Costs. China’s consumer Inflation. CASH- Cost and availability of cash is changing which means that there is again a cost associated to taking risk = investors start being more selective. ATTRACTIVITY- In this context, attractivity of the AH sector is increased, especially in Pets, given the track record of resilience of the sector vs. other investment opportunities. We will continue to see M&A activity and R&D investment in the sector. CORPORATIZATION- Despite the increased cost of money, the predictability and history of AH and veterinary business in the last financial crises and the early stage of vet clinics consolidations in many markets are strong drivers for continued, fast-paced corporatization to continue. PET PARENT AND CONSUMER POWER- It will continue to increase in the AH, with megatrends like online 24/7 availability omnichannel, pet as family member, steady increase of pet plans / pet insurance / data driven personalization. This creates value in the market for agile companies. Transactional Customers- Know what they want, Treat you as commodity, Digital interaction, Cost focus, Buy on price, Short term. Consultative Customers- Share problems, Value your value add, Digital & analogue interaction, Advice focus, Buy on expertise and trust, Long term. Vet Landscape Evolution 2022-2025. Market consolidation. Independent Vet clinics. Companion Animals. Corporates. GPOs. Corporate landscape in Europe (data Q2 2022)- A number of large, well capitalized veterinary strategic accounts are expanding. Global trends in pet population. There are currently billions of pets worldwide. Pet ownership is rising globally, particularly in millennial households. Expanding middle class is driving pet population growth in emerging markets. Pet ownership leads to improved human health outcomes for people including better heart health, lower levels of depression and anxiety, etc. Brands & blockbusters. Increasing brand value. Zoetis, Elanco (and BI indirectly through their sales reporting) qualify blocbkusters as products > $100m – 25 brands. One Heath Concept. Sustainability. Technology innovation. Veterinary / Nurse shortage. Farms, trades, on-line shop, independent. More customers are moving to the extremes. More want deeper consultative relationships. More buy transactionally

mHealth Israel- Animal Health Landscape

Levi Shapiro

Human and Animal Healthcare- Where do they meet? Sept 29, 2022 animal health presentation by Cindy Cole, Partner, Digitalis Ventures. Overview of Digitalis Ventures and their $100 million Companion Fund, Mars-backed VC Fund dedicated to the companion animal space. Context about solving a problem vs creating a want. For example, dogs are not small humans. Specific Opportunities include supplements. This is a huge market, very fragmented, Very little science to support the activies. How do you differentiate your products? Example of Telemedicine- a cautionary tale for startups and investors. Summary- if your coming from human healthcare…Understand dogs and cats, Don’t over index on the “humanization” of pets, Solving a problem or creating a want. YouTube video recording available, along with other presenters, Ila Shukla Roof, Executive Commercial Director, Covetrus; Andras Bolcksei, Executive Vice President and Global Commercial Lead, CENA Sante; Avner Finger, VP Global R&D- Vaccines, Phibro; Moderated by Gil Bashe, Head of Global Health and PURPOSE, Finn Partners.

mHealth Israel: Human and Animal Healthcare- Where do they meet? Presentation...

Levi Shapiro

More from Levi Shapiro (20)

Baptist Health- Engineering the Future of Healthcare

YEDA Techn Transfer at Weizmann Institute- Discord and Challenges in Academic...

HADASIT: Tech Transfer and More in Life Science

Presenting to Investors & the Media.pdf

Nissan Elimelech, Founder, Augmedics: How I Built the World's First XR Surgic...

Beyeonics CEO, Ron Schneider, Advances in Medical XR

XRHealth Founder, Miki Levy

Digital Health in US Health Systems.pptx

Course Syllabus (Digital Rosh): The Future of Digital Medicine- Biology, Gene...

Alagene BioFoundry: Releasing the Genie Out of the Bottle

Digital Health Ecosystem- 2022 3rd Quarter Report

EU Medical Device Regulatory Framework_Dec, 2022

FINN Partners Global State of Digital Health Q3 2022

Digitally powered participant-directed studies- Strategy for Decentralized Ca...

AI and the Future of Healthcare, Siemens Healthineers

A Peek into the Future of Health Systems, Mark Coticchia, Baptist Health

mHealth Israel: The Speed of Change is Faster Than Our Response_Howard Yana S...

mHealth Israel_Unmet Needs and Opportunities – Farm animals

mHealth Israel- Animal Health Landscape

mHealth Israel: Human and Animal Healthcare- Where do they meet? Presentation...

Recently uploaded

Explore the innovative world of Video Capsule Endoscopy (VCE) and its applications in pediatric care. This SlideShare presentation covers the procedure, benefits, and considerations for using VCE in children. Learn how this non-invasive diagnostic tool is revolutionizing the detection and treatment of gastrointestinal conditions in young patients, offering a safer and more comfortable alternative to traditional methods.

Video capsule endoscopy (VCE ) in children

Raju678948

Premium ℂall Girls In Mira Road👉 Dail ℂALL ME: 📞9004268417 📲 ℂall Richa VIP ℂ...

Rabia Malik

Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...

Health Kinesiology Natural Bioenergetics

ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO

Kanhu Charan

VVIP Yelahanka ℂall Girls 6350482085 Heat-immolating { Bangalore } Coveted Gi...

janusa9823#S0007

VVIP Whitefield ℂall Girls 6350482085 Heat-flaring { Bangalore } Worthy Girl ...

janusa9823#S0007

Tips to Choose the Best Psychiatrists in Indore

Gokuldas Hospital

DR. Neha Mehta Best Psychologist.in India

Nehamehta128467

Dermatome and myotome test & pathology.pdf

niloofarbarzegari76

Evidence-based practiceEBP) in physiotherapy

Nehaa Dubey

Vip ℂall Girls Shalimar Bagh Phone No 9999965857 High Profile ℂall Girl Delhi...

jiyav969

TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...

marcuskenyatta275

Saudi Arabia [ Abortion pills) Jeddah/riaydh/dammam/++918133066128☎️] cytotec tablets uses abortion pills 💊💊 How effective is the abortion pill? 💊💊 +918133066128) "Abortion pills in Jeddah" how to get cytotec tablets in Riyadh " Abortion pills in dammam*💊💊 The abortion pill is very effective. If you’re taking mifepristone and misoprostol, it depends on how far along the pregnancy is, and how many doses of medicine you take:💊💊 +918133066128) how to buy cytotec pills At 8 weeks pregnant or less, it works about 94-98% of the time. +918133066128[ 💊💊💊 At 8-9 weeks pregnant, it works about 94-96% of the time. +918133066128) At 9-10 weeks pregnant, it works about 91-93% of the time. +918133066128)💊💊 If you take an extra dose of misoprostol, it works about 99% of the time. At 10-11 weeks pregnant, it works about 87% of the time. +918133066128) If you take an extra dose of misoprostol, it works about 98% of the time. In general, taking both mifepristone and+918133066128 misoprostol works a bit better than taking misoprostol only. +918133066128 Taking misoprostol alone works to end the+918133066128 pregnancy about 85-95% of the time — depending on how far along the+918133066128 pregnancy is and how you take the medicine. +918133066128 The abortion pill usually works, but if it doesn’t, you can take more medicine or have an in-clinic abortion. +918133066128 When can I take the abortion pill?+918133066128 In general, you can have a medication abortion up to 77 days (11 weeks)+918133066128 after the first day of your last period. If it’s been 78 days or more since the first day of your last+918133066128 period, you can have an in-clinic abortion to end your pregnancy.+918133066128 Why do people choose the abortion pill? Which kind of abortion you choose all depends on your personal+918133066128 preference and situation. With+918133066128 medication+918133066128 abortion, some people like that you don’t need to have a procedure in a doctor’s office. You can have your medication abortion on your own+918133066128 schedule, at home or in another comfortable place that you choose.+918133066128 You get to decide who you want to be with during your abortion, or you can go it alone. Because+918133066128 medication abortion is similar to a miscarriage, many people feel like it’s more “natural” and less invasive. And some+918133066128 people may not have an in-clinic abortion provider close by, so abortion pills are more available to+918133066128 them. +918133066128 Your doctor, nurse, or health center staff can help you decide which kind of abortion is best for you. +918133066128 More questions from patients: Saudi Arabia+918133066128 CYTOTEC Misoprostol Tablets. Misoprostol is a medication that can prevent stomach ulcers if you also take NSAID medications. It reduces the amount of acid in your stomach, which protects your stomach lining. The brand name of this medication is Cytotec®.+918133066128) Unwanted Kit is a combination of two medicines, which i

In Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait City

Abortion pills in Kuwait Cytotec pills in Kuwait

Cervical screening – taking care of your health flipchart (Vietnamese)

Cancer Institute NSW

Co-Chairs and Presenter Marianne Davies, DNP, ACNP, AOCNP, FAAN, Beth Sandy, MSN, CRNP, FAPO, and Matthew A. Gubens, MD, MS, FASCO, prepared useful Practice Aids pertaining to NSCLC for this CME/MOC/NCPD/ILNA/IPCE activity titled “Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices for Patient Education, irAE Management, and Survivorship Care.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/ILNA/IPCE information, and to apply for credit, please visit us at https://bit.ly/3RDokbZ. CME/MOC/NCPD/ILNA/IPCE credit will be available until May 24, 2025.

Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...

PVI, PeerView Institute for Medical Education

HIFI* ℂall Girls In Thane West Phone 🔝 9920874524 🔝 💃 Me All Time Serviℂe Ava...

Ishita Kashyap

Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة

Mohamad محمد Al-Gailani الكيلاني

Our Hottest 💘 Surat ℂall Girls Serviℂe 💘Pasodara📱 8527049040📱450+ ℂall Girl C...

Aditi Pandey i11

ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx

Dr. Sohan Biswas

5cladba raw material 5CL-ADB-A precursor raw Packing & Delivery Package : foil drums/bags to pack solid. Bottles and drums for liquid. We can also provide Customized service such as custom packaging. Delivery : 1.In about 5 working days after the receipt of payment, we will follow up the delivery until you receive it. 2.Express way as the following is: (Shipping : TNT,Fedex,DHL,UPS,EMS and so on)

5cladba raw material 5CL-ADB-A precursor raw

Sherrylee83

Recently uploaded (20)